Net Result from Core Activities: EUR244 million, higher than the outlook. Gross Rental Revenue: Up nearly 2% on a like-for-like basis. Cost of Debt: Stable at 1.4%. Debt to Asset Ratio: 42.6%. Healthcare Real Estate Portfolio: 77% of the EUR6 billion portfolio. Occupancy Rate: Very high at 98.5%. Gross Yield: Slightly expanded at 5.9%, net yield at 5.6%. EPRA Earnings Per Share (EPS): EUR6.50 per share. IFRS Net Result: EUR64 million or EUR1.7 per share. Fair Value of Healthcare Portfolio: EUR4.6 billion. Office Segment Fair Value: EUR829 million. Total Assets: Approximately EUR6.4 billion. Dividend Proposal for 2024: EUR6.20 per share. Investment Budget for 2025: EUR170 million. Target Divestment for 2025: EUR100 million. Projected Net Investment for 2025: EUR70 million. 2025 EPS Target: EUR6.20 per share. Projected 2025 Dividend: EUR5.20 per share.

Warning! GuruFocus has detected 7 Warning Signs with WBO:COFB.

Release Date: February 21, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Cofinimmo SA/NV (WBO:COFB) achieved a net result from core activities higher than the outlook at EUR244 million. The company maintained a high occupancy rate of 98.5% across its property portfolio. Healthcare real estate now constitutes 77% of Cofinimmo's EUR6 billion portfolio, reflecting strategic growth in this sector. Cofinimmo's cost of debt remains stable at 1.4%, one of the lowest levels for REITs in Europe. The company is recognized as one of the most sustainable companies in Europe by the Financial Times and Time Magazine.

Negative Points

The office segment has been reduced significantly, now representing only 15% of the portfolio, which may limit diversification. The fair value of investment properties decreased by 1.9% in 2024, reflecting market challenges. The company anticipates a slight increase in the cost of debt to 1.5% in 2025, with a gradual rise expected to 2.2% by 2028. Cofinimmo's dividend for 2025 is projected to decrease to EUR5.20 per share, reflecting a payout ratio of 84%. The company faces challenges in the office market, with a muted environment in Belgium affecting divestment strategies.

Q & A Highlights

Q: Your operating margin improved significantly during the year. Is this sustainable, or was it a one-off in 2024? A: Jean-Pierre Hanin, CEO: We maintain tight control over costs and company management. While inflation indexation is present, we compensate through other measures to sustain this margin.

Q: Regarding investments, are you seeing more opportunities in acquisitions or developments? A: Jean-Pierre Hanin, CEO: It varies by geography. In some areas, development is limited due to high construction costs, while in others, healthcare operators are considering growth. Our guidance considers both acquisitions and developments.

Story Continues

Q: Can you provide more detail on the like-for-like rental decrease of 1%? Is it mainly from the office or healthcare sector? A: Jean-Pierre Hanin, CEO: It's a mix of both. In healthcare, it involved negotiations where we exchanged concessions for longer lease terms. We don't expect this level of impact in the future.

Q: What is your strategy for office disposals? Are you looking for minority shareholders or selling asset by asset? A: Jean-Pierre Hanin, CEO: We are open to both strategies. We are not waiting for a portfolio stake buyer and are actively pursuing asset-by-asset sales. The dividend adjustment anticipates progressive office divestment.

Q: Could you comment on the leasing activity in the MO10 building? A: Jean-Pierre Hanin, CEO: Leasing is progressing well, with delivery completed last year. We recorded prime rent and expect to complete occupancy in 2025.

Q: What is your outlook for like-for-like portfolio value in 2025? A: Jean-Pierre Hanin, CEO: We aimed to clean the balance sheet in 2024. With a stable interest environment, we expect stabilization and potential improvement in portfolio value.

Q: How do you plan to fund growth, and do you foresee any capital increases in 2025? A: Jean-Pierre Hanin, CEO: We plan to use the office portfolio for growth and have no planned equity increases. We aim to maintain a stable debt-to-asset ratio around 43% by year-end 2025.

Q: Could you elaborate on the impact of divestments on earnings? A: Jean-Pierre Hanin, CEO: The decrease in EPS is linked to divestments over the last year, not necessarily yield changes. Selling high-yield offices and reinvesting in healthcare can result in lower yields.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

View Comments